Teri Loxam

Ms. Teri Loxam is a Chief Financial & Accounting Officer at Compass Pathways Plc, an Independent Director at Cardiol Therapeutics, Inc., a Chief Operating Officer at Kira Pharmaceuticals (Hong Kong) Ltd. and an Independent Director at Vaxcyte, Inc. She is on the Board of Directors at Cardiol Therapeutics, Inc. and Vaxcyte, Inc. Ms. Loxam was previously employed as a Chief Financial Officer by Gameto, Inc., a Chief Operating & Financial Officer by Kira Pharmaceuticals (US) LLC, a Chief Financial Officer by SQZ Biotechnologies Co., a Senior Vice President-Investor Relations by Merck & Co., Inc., a Vice President-Investor Relations by IMAX Corp., a Vice President-Investor Relations by IMAX Corp.
(Oklahoma), and a Director-Investor Relations by Bristol Myers Squibb Co. She received her undergraduate degree from the University of Victoria and an MBA from Paul Merage School of Business.